Fallon Pharmacy Recalls Bevacizumab Syringes Due to Sterility Concerns
Fallon Wellness Pharmacy is recalling 241 prefilled Bevacizumab syringes because third-party testing suggests sterility test results may have been inaccurate.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant safety concern like sterility assurance in a drug product warrants a score of 4 (Severe), particularly given the potential for serious infection if the product is not sterile.
Plain-English summary
Fallon Wellness Pharmacy, located in Latham, New York, is recalling 241 prefilled syringes of Bevacizumab 25mg/mL. The affected product is available in 0.05 mL and 0.06 mL sizes. The specific lot number is 08052013@84, with an expiration date of 11/5/2013.
The recall was initiated due to a lack of assurance of sterility. Third-party laboratory testing indicated that previous test results reported as passing sterility may have been inaccurate. This raises concerns that the product may not be sterile.
The affected syringes were distributed in New York and Maine. Patients who received this medication should contact their healthcare provider or pharmacist for further instructions on what to do with the remaining product.
The recalled product
- Product
- Bevacizumab 25mg/mL, prepared as pre-filled syringes in 0.05 mL and 0.06 mL sizes, Fallon Wellness Pharmacy, Latham, NY 12110.
- Manufacturer
- Fallon Wellness Pharmacy Llc
- Category
- Drug — Biologic / Injectable
- Hazard
- Affected units
- 241
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 08052013@84
- Exp 11/5/2013
Distribution
Related recalls
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29